PP2

Target: This ligand targets Src-family tyrosine kinases in biochemical or cellular target-engagement studies.

Mechanism of Action: Used as the target-protein recognition element, this ligand provides the binding interface for Src-family tyrosine kinases. In PROTAC design, a derivatizable position on the ligand can be connected through an optimized linker to an E3 ligase ligand, such as a CRBN, VHL, or IAP recruiter, while preserving productive target engagement. The resulting bifunctional molecule brings Src-family tyrosine kinases into proximity with the recruited E3 ligase, enabling ternary-complex formation. If the complex has favorable geometry and residence time, target lysine ubiquitination is promoted, leading to proteasome-dependent degradation in experimental systems.

• PROTAC E3 Ligase Recruiting: PP2 can serve as a kinase-binding warhead to direct PROTAC-mediated degradation of selected serine/threonine kinases. By conjugating PP2 to an E3 ligase ligand, researchers can test whether ternary complex formation enhances ubiquitination and proteasomal turnover, enabling functional knockdown beyond inhibition through degradation-driven pathway rewiring.

• Kinase Degradation Mechanism Studies: PP2-based PROTACs are useful for dissecting degradation mechanisms for kinase targets, including requirements for ternary complex stability, ubiquitin transfer efficiency, and proteasome dependence. Systematic variation of linker length and attachment sites can reveal how PP2 engagement influences residence time and degradation kinetics, supporting rational design of next-generation chimeras.

• Target Specificity and Off-Target Mapping: PP2 warheads can be deployed in PROTAC formats to evaluate target selectivity across kinase families. Comparing degradation profiles with corresponding inhibitors helps distinguish degradation-driven phenotypes from catalytic blockade effects, while proteomics-based readouts can map off-target recruitment and unintended degradation, guiding refinement of warhead choice and E3 ligase pairing.

• Functional Phenotype Rescue Experiments: PP2-driven PROTACs enable experiments that separate kinase catalytic inhibition from protein removal. By inducing degradation and then assessing pathway outputs, researchers can perform rescue studies using degradation-resistant mutants to confirm causality. This approach supports mechanistic validation of how loss of the PP2-bound kinase alters signaling networks and cellular phenotypes.

PP2 is a pyrazolopyrimidine kinase ligand scaffold commonly used for Src-family kinase research and can guide kinase-directed degrader design. Its compact heteroaromatic core and hydrophobic aryl substituents make linker-vector selection especially important.

Structure: PP2 is 1-tert-butyl-3-(4-chlorophenyl)pyrazolo[3,4-d]pyrimidin-4-amine. The molecule contains a fused pyrazolopyrimidine heteroaromatic core, an exocyclic 4-amino group, a tert-butyl substituent, and a para-chlorophenyl group, forming a rigid kinase-recognition scaffold with hydrogen-bond donor/acceptor features and hydrophobic aryl contacts.

Reactivity: For PROTAC construction, the pyrazolopyrimidine core and exocyclic amino group should generally be preserved to maintain kinase binding. Linker installation is best explored through designed PP2 analogs bearing a tolerated exit vector on the chlorophenyl ring or tert-butyl-associated periphery rather than by directly modifying the parent scaffold. Alkyl, PEG, amide, carbamate, or aryl-linker systems may be paired with CRBN, VHL, IAP, or other E3 ligase ligands after confirming that Src-family kinase engagement is retained.